secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dianthus Therapeutics, Inc. /DE/ (DNTH)
CIK:        0001690585
Form:       8-K
Filed at:   2022-06-30T23:59:59+00:00
Accession:  0001193125-22-186149
Event type: other
Sentiment:  neutral
Materiality: 0.05
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Magenta Therapeutics elects Daniel and Ronneberg as Class I directors at annual meeting
--------------------------------------------------------------------------------

- Thomas O. Daniel, M.D. received 29,064,311 votes for and 7,962,396 withheld.
- Amy Lynn Ronneberg received 27,364,344 votes for and 9,662,363 withheld.
- Ratification of KPMG as auditor passed with 52,877,344 for, 249,235 against.
- Broker non-votes totaled 16,120,189 on director elections.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1690585/000119312522186149/0001193125-22-186149-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1690585/000119312522186149/d364913d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-186149

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer